Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sarepta Therapeutics Company Profile (NASDAQ:SRPT)

Consensus Ratings for Sarepta Therapeutics (NASDAQ:SRPT) (?)
Ratings Breakdown: 10 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $27.88 (97.98% upside)

Current Analysts' Coverage Summary for Sarepta Therapeutics (NASDAQ:SRPT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/2/2015Needham & Company LLCLower Price TargetBuy$52.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015Canaccord GenuitySet Price TargetHold$16.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015Robert W. BairdReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
2/27/2015Cowen and CompanyDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
2/20/2015Roth CapitalSet Price TargetBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
2/17/2015Bank of AmericaUpgradeNeutral -> Buy$19.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
2/4/2015SunTrustInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
1/27/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$3.00ViewTweet This Rating  Share This Rating on StockTwits
1/22/2015RBC CapitalInitiated CoverageSector Perform$15.00ViewTweet This Rating  Share This Rating on StockTwits
1/20/2015WedbushDowngradeOutperform -> Neutral$16.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2015WBB SecuritiesReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/11/2014ZacksReiterated RatingNeutral -> Neutral$17.00ViewTweet This Rating  Share This Rating on StockTwits
10/27/2014Stifel NicolausDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
10/27/2014JMP SecuritiesDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
10/7/2014Credit SuisseReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
7/31/2014OppenheimerInitiated CoverageOutperform$45.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2014Deutsche BankReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
4/22/2014Citigroup Inc.UpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/21/2014William BlairUpgradeMarket Perform -> Outperform$63.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/23/2013Piper JaffrayUpgradeUnderweight -> Neutral$19.55 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Leerink SwannLower Price TargetMarket Perform$44.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013FBR Capital MarketsLower Price TargetMarket Perform$48.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
11/12/2013Janney Montgomery ScottDowngradeNeutral -> SellViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & CoInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
7/24/2013Burrill Institutional ResearchDowngradeOutperform -> Market Perform$39.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/6/2013 forward)